U.S. EPA Supports Bayer’s Appeal of Roundup Cancer Verdict
- Government urges appeals court to overturn jury finding
- EPA says states can’t impose distinct labeling requirements
This article is for subscribers only.
The U.S. is weighing in on Bayer AG ’s side in its appeal of the first, and so far only, federal jury verdict finding the company’s Roundup weed killer causes cancer.
U.S. District Judge Vince Chhabria in July slashed the March verdict to $25 million from more than $80 million. He refused though to overturn the jury’s finding that Roundup is defective because it’s sold without a cancer warning.
In a filing Friday to a San Francisco-based appeals court, the U.S. Environmental Protection Agency argued that the jury’s finding should be overturned.